News Focus
News Focus
Replies to #84053 on Biotech Values
icon url

mouton29

09/24/09 11:41 AM

#84054 RE: biomaven0 #84053

<<I do grant that some non-lawyers use the term "secondary" more broadly to cover all sorts of follow-on offerings. >>

I am ashamed to report that I hear corporate lawyers at large law corporate law misusing the "secondary" term quite frequently -- so frequently, that it is dangerous to assume you know what they mean. Just as, if someone tells you that they "perused" a document, it is foolish to assume that they meant "read carefully."

<< No member of the public can automatically acquire shares in an underwritten offering - it's up to the underwriters to decide who gets them.>>

That's true, but when I think of the typical public offering, at least I have a chance to call up a broker and beg for an allocation and he can at least check around. In this case, there was no syndicate -- only LS -- and no publicity so there was no way for me to even make a call were I so inclined.
icon url

wallstarb

09/24/09 12:33 PM

#84057 RE: biomaven0 #84053

I'm not a lawyer - but I use these terms nearly daily in the course of running our funds. The way most professionals use the terms are as I explained.

And no I have no idea what investipedia is. But this offering was not made public. therefore its private anyway you cut it.

It looks like MNTA may lose the 10.75 level if the market sees more weakness. If that happens I guess most here will be happy that it wasn't a public offering!

10.20 - 10.40 area though has a lot of support in the moving averages clusters.